Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
Tumours with homologous recombination (HR) defects become sensitive to PARPi. Here, the authors show that androgen receptor (AR) regulates HR and AR inhibition activates the PARP pathway in vivo, thus inhibition of both AR and PARP is required for effective treatment of high risk prostate cancer.
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6dd1f31e993c4c649fd8af898835fe41 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6dd1f31e993c4c649fd8af898835fe41 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6dd1f31e993c4c649fd8af898835fe412021-12-02T15:38:57ZSynthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer10.1038/s41467-017-00393-y2041-1723https://doaj.org/article/6dd1f31e993c4c649fd8af898835fe412017-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-00393-yhttps://doaj.org/toc/2041-1723Tumours with homologous recombination (HR) defects become sensitive to PARPi. Here, the authors show that androgen receptor (AR) regulates HR and AR inhibition activates the PARP pathway in vivo, thus inhibition of both AR and PARP is required for effective treatment of high risk prostate cancer.Mohammad AsimFiras TarishHeather I. ZecchiniKumar SanjivEleni GelaliCharles E. MassieAjoeb BaridiAnne Y. WarrenWanfeng ZhaoChristoph OgrisLeigh-Anne McDuffusPatrice MascalchiGreg ShawHarveer DevKaran WadhwaPaul WijnhovenJosep V. FormentScott R. LyonsAndy G. LynchCormac O’NeillVincent R. ZecchiniPaul S. RennieAria BaniahmadSimon TavaréIan G. MillsYaron GalantyNicola CrosettoNiklas SchultzDavid NealThomas HelledayNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-10 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Mohammad Asim Firas Tarish Heather I. Zecchini Kumar Sanjiv Eleni Gelali Charles E. Massie Ajoeb Baridi Anne Y. Warren Wanfeng Zhao Christoph Ogris Leigh-Anne McDuffus Patrice Mascalchi Greg Shaw Harveer Dev Karan Wadhwa Paul Wijnhoven Josep V. Forment Scott R. Lyons Andy G. Lynch Cormac O’Neill Vincent R. Zecchini Paul S. Rennie Aria Baniahmad Simon Tavaré Ian G. Mills Yaron Galanty Nicola Crosetto Niklas Schultz David Neal Thomas Helleday Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer |
description |
Tumours with homologous recombination (HR) defects become sensitive to PARPi. Here, the authors show that androgen receptor (AR) regulates HR and AR inhibition activates the PARP pathway in vivo, thus inhibition of both AR and PARP is required for effective treatment of high risk prostate cancer. |
format |
article |
author |
Mohammad Asim Firas Tarish Heather I. Zecchini Kumar Sanjiv Eleni Gelali Charles E. Massie Ajoeb Baridi Anne Y. Warren Wanfeng Zhao Christoph Ogris Leigh-Anne McDuffus Patrice Mascalchi Greg Shaw Harveer Dev Karan Wadhwa Paul Wijnhoven Josep V. Forment Scott R. Lyons Andy G. Lynch Cormac O’Neill Vincent R. Zecchini Paul S. Rennie Aria Baniahmad Simon Tavaré Ian G. Mills Yaron Galanty Nicola Crosetto Niklas Schultz David Neal Thomas Helleday |
author_facet |
Mohammad Asim Firas Tarish Heather I. Zecchini Kumar Sanjiv Eleni Gelali Charles E. Massie Ajoeb Baridi Anne Y. Warren Wanfeng Zhao Christoph Ogris Leigh-Anne McDuffus Patrice Mascalchi Greg Shaw Harveer Dev Karan Wadhwa Paul Wijnhoven Josep V. Forment Scott R. Lyons Andy G. Lynch Cormac O’Neill Vincent R. Zecchini Paul S. Rennie Aria Baniahmad Simon Tavaré Ian G. Mills Yaron Galanty Nicola Crosetto Niklas Schultz David Neal Thomas Helleday |
author_sort |
Mohammad Asim |
title |
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer |
title_short |
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer |
title_full |
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer |
title_fullStr |
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer |
title_full_unstemmed |
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer |
title_sort |
synthetic lethality between androgen receptor signalling and the parp pathway in prostate cancer |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/6dd1f31e993c4c649fd8af898835fe41 |
work_keys_str_mv |
AT mohammadasim syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT firastarish syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT heatherizecchini syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT kumarsanjiv syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT elenigelali syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT charlesemassie syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT ajoebbaridi syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT anneywarren syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT wanfengzhao syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT christophogris syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT leighannemcduffus syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT patricemascalchi syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT gregshaw syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT harveerdev syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT karanwadhwa syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT paulwijnhoven syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT josepvforment syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT scottrlyons syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT andyglynch syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT cormaconeill syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT vincentrzecchini syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT paulsrennie syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT ariabaniahmad syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT simontavare syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT iangmills syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT yarongalanty syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT nicolacrosetto syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT niklasschultz syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT davidneal syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer AT thomashelleday syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer |
_version_ |
1718385993977954304 |